Literature DB >> 22402072

Outcomes in patients with heart failure with preserved ejection fraction: it is more than the heart.

Dalane W Kitzman.   

Abstract

Entities:  

Mesh：

Year:  2012        PMID： 22402072     DOI： 10.1016/j.jacc.2011.12.011

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN： 0735-1097            Impact factor:   24.094


× No keyword cloud information.
  8 in total

1.  Rehabilitation Therapy in Older Acute Heart Failure Patients (REHAB-HF) trial: Design and rationale.

Authors:  Gordon R Reeves; David J Whellan; Pamela Duncan; Christopher M O'Connor; Amy M Pastva; Joel D Eggebeen; Leigh Ann Hewston; Timothy M Morgan; Shelby D Reed; W Jack Rejeski; Robert J Mentz; Paul B Rosenberg; Dalane W Kitzman
Journal:  Am Heart J       Date:  2016-12-28       Impact factor: 4.749

2.  Usefulness of Doppler echocardiographic left ventricular diastolic function and peak exercise oxygen consumption to predict cardiovascular outcomes in patients with systolic heart failure (from HF-ACTION).

Authors:  Julius M Gardin; Eric S Leifer; Dalane W Kitzman; Gerald Cohen; Joel S Landzberg; William Cotts; Eugene E Wolfel; Robert E Safford; Renee L Bess; Jerome L Fleg
Journal:  Am J Cardiol       Date:  2012-06-08       Impact factor: 2.778

3.  Treating anemia in older adults with heart failure with a preserved ejection fraction with epoetin alfa: single-blind randomized clinical trial of safety and efficacy.

Authors:  Mathew S Maurer; Sergio Teruya; Bibhas Chakraborty; Stephen Helmke; Donna Mancini
Journal:  Circ Heart Fail       Date:  2012-12-20       Impact factor: 8.790

4.  Risk factors for rehospitalization in heart failure with preserved ejection fraction compared with reduced ejection fraction.

Authors:  Masahiko Setoguchi; Yuji Hashimoto; Taro Sasaoka; Takashi Ashikaga; Mitsuaki Isobe
Journal:  Heart Vessels       Date:  2014-06-17       Impact factor: 2.037

5.  Heart failure with preserved ejection fraction in African Americans: The ARIC (Atherosclerosis Risk In Communities) study.

Authors:  Deepak K Gupta; Amil M Shah; Davide Castagno; Madoka Takeuchi; Laura R Loehr; Ervin R Fox; Kenneth R Butler; Thomas H Mosley; Dalane W Kitzman; Scott D Solomon
Journal:  JACC Heart Fail       Date:  2013-04       Impact factor: 12.035

6.  Strategies for supporting intervention fidelity in the rehabilitation therapy in older acute heart failure patients (REHAB-HF) trial.

Authors:  Amy M Pastva; Pamela W Duncan; Gordon R Reeves; M Benjamin Nelson; David J Whellan; Christopher M O'Connor; Joel D Eggebeen; Leigh Ann Hewston; Karen M Taylor; Robert J Mentz; Paul B Rosenberg; Dalane W Kitzman
Journal:  Contemp Clin Trials       Date:  2017-10-25       Impact factor: 2.226

7.  Diastolic heart failure: What we still don't know. Looking for new concepts, diagnostic approaches, and the role of comorbidities.

Authors:  C Tschöpe; C S P Lam
Journal:  Herz       Date:  2012-12       Impact factor: 1.443

8.  Beta-blockers in older patients with heart failure and preserved ejection fraction: class, dosage, and outcomes.

Authors:  Kanan Patel; Gregg C Fonarow; O James Ekundayo; Inmaculada B Aban; Meredith L Kilgore; Thomas E Love; Dalane W Kitzman; Mihai Gheorghiade; Richard M Allman; Ali Ahmed
Journal:  Int J Cardiol       Date:  2014-03-11       Impact factor: 4.164
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.